<DOC>
	<DOCNO>NCT01181622</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability denufosol 60 mg TID pediatric CF patient 2 4 year age</brief_summary>
	<brief_title>A Safety Tolerability Study Denufosol 2-4 Year Olds</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Have confirm diagnosis CF Have oxyhemoglobin saturation â‰¥ 95 % prior randomization Have acute intercurrent respiratory infection ( cough , wheeze , new rhinorrhea nasal congestion ) Have significant medical condition relate CF Unable discontinue use hypertonic saline</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>